Literature DB >> 6245246

Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus.

S K Weller, A E Joy, H M Temin.   

Abstract

Avian leukosis viruses of subgroups B, D, and F are cytopathic for chicken cells, whereas viruses of subgroups A, C, and E are not. The amounts of unintegrated linear viral DNA in cells at different times after infection with cytopathic or noncytopathic viruses were determined by hybridization and transfection assays. Shortly after infection, there is a transient accumulation of unintegrated linear viral DNA in cells infected with cytopathic avian leukosis viruses. By 10 days after infection, the majority of this unintegrated viral DNA is not present in the infected cells. The transient cytopathic effect seen in these infected cells also disappears by this time. Low amounts of unintegrated linear viral DNA persist in these cells. Cells infected with noncytopathic viruses do not show this transient accumulation of unintegrated viral DNA. Cells infected with cytopathic viruses and subsequently grown in the presence of neutralizing antibody do not show the transient accumulation of unintegrated viral DNA or cytopathic effects. These results demonstrate a correlation between envelope subgroup, transient accumulation of unintegrated linear viral DNA, and transient cell killing by avian leukosis viruses. The cell killing appears to be the result of massive second-round superinfection by the cytopathic avian leukosis viruses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245246      PMCID: PMC288564     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Plaque assay for some strains of avian leukosis virus.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

2.  A cell-associated factor essential for formation of an infectious form of Rous sarcoma virus.

Authors:  H Hanafusa; T Miyamoto; T Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

3.  Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses.

Authors:  C Altaner; H M Temin
Journal:  Virology       Date:  1970-01       Impact factor: 3.616

4.  A plaque assay for avian RNA tumor viruses.

Authors:  T Graf
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

5.  Studies on carcinogenesis by avian sarcoma viruses. 8. Glycolysis and cell multiplication.

Authors:  H M Temin
Journal:  Int J Cancer       Date:  1968-03-15       Impact factor: 7.396

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Patterns of viral interference in the avian leukosis and sarcoma complex.

Authors:  P K Vogt; R Ishizaki
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

8.  The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference.

Authors:  F T Steck; H Rubin
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

9.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

10.  Comparison of Rous sarcoma virus-specific deoxyribonucleic acid polymerases in virions of Rous sarcoma virus and in Rous sarcoma virus-infected chicken cells.

Authors:  J M Coffin; H M Temin
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

View more
  84 in total

1.  TVB receptors for cytopathic and noncytopathic subgroups of avian leukosis viruses are functional death receptors.

Authors:  J Brojatsch; J Naughton; H B Adkins; J A Young
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.

Authors:  Daniel J Knauss; John A T Young
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency.

Authors:  Chi-Wei Lu; Lucille O'Reilly; Monica J Roth
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Lymphoid leukosis viruses, their recognition as 'persistent' viruses and comparisons with certain other retroviruses of veterinary importance.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

5.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Neutralizing antibodies modulate replication of simian immunodeficiency virus SIVmac in primary macaque macrophages.

Authors:  M F McEntee; M C Zink; M G Anderson; H Farzadegan; R J Adams; K A Kent; E J Stott; J E Clements; O Narayan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Bystander killing during avian leukosis virus subgroup B infection requires TVB(S3) signaling.

Authors:  Felipe Diaz-Griffero; Steven A Hoschander; Jürgen Brojatsch
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

9.  Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.

Authors:  Deborah C Melder; V Shane Pankratz; Mark J Federspiel
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.